NCT04844151 (AMPHIBIA) is a clinical trial in Myocarditis, sponsored by Assistance Publique - Hôpitaux de Paris.

Who is sponsoring NCT04844151?

NCT04844151 is sponsored by Assistance Publique - Hôpitaux de Paris.

What condition does NCT04844151 study?

NCT04844151 studies Myocarditis.

Is NCT04844151 still recruiting?

NCT04844151 is currently recruiting now. Last updated 6 June 2025.

Last reviewed 2025-06-06 · How we verify

NCT04844151: AMPHIBIA

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acute Myocarditis Registry With Prognostic, Histologic, Immunologic, Biological, Imaging and Clinical Assessment

Recruiting now Last updated 6 June 2025

What this trial tests

trial in Myocarditis in 1,400 participants. Currently enrolling.

Timeline

23 January 2022

Primary endpoint
1 May 2041

1 May 2041

Quick facts

Lead sponsor	Assistance Publique - Hôpitaux de Paris
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	1,400
Start date	23 January 2022
Primary completion	1 May 2041
Estimated completion	1 May 2041
Sites	1 location across France

Conditions studied

Myocarditis — all drugs for Myocarditis →

Sponsor

Assistance Publique - Hôpitaux de Paris — full company profile →

Who can join

15 and older, any sex, with Myocarditis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The AMPHIBIA study is an observational ambispective and prospective cohort that aim to describe the histologic, immunologic, biological, imaging, genetic and clinical characteristics of the patients hospitalized for an acute myocarditis and to evaluate their association with prognosis.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Anti-RNApol3-Associated myocarditis: an emerging disease linking autoimmunity and infection.
Quentric P, Charuel JL, Moyon Q, Hékimian G, et al · · 2025 · cited 1× · PMID 40123018 · DOI 10.1186/s13613-025-01443-1
Rationale and design of the Pre-MYO project: a precision-medicine platform for myocarditis diagnosis and management.
Pascual-Figal DA, García-Serna AM, Esteban-Gil A, Fuster JJ, et al · · 2026 · PMID 41711201 · DOI 10.1093/eschf/xvag022

Verify or expand the search:

Other recruiting trials for Myocarditis

Currently open trials in the same condition.

NCT06889662 — GEAM Study Aims At Assessing the Role of Genetic Testing in Patients with Arrhythmic Myocarditis. · recruiting
NCT06730607 — Image-Based Prediction of Ventricular Tachycardias in Post-Myocarditis Patients: an International Multicenter Case-contr · recruiting
NCT06566209 — FDG-PET as an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis · recruiting
NCT07086144 — Efficacy of a Myocardial Panel in the Management and Treatment of Pediatric Myocarditis · NA · recruiting
NCT06158698 — CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine · Phase 3 · recruiting

Other Assistance Publique - Hôpitaux de Paris trials

Trials by the same sponsor.

NCT07443436 — Immunomodulatory Treatment of Interstitial Lung Disease Associated With Surfactant Related Gene Variants · Phase 2 · not yet recruiting
NCT07499492 — Red Blood Cell Transfusion to Optimize Extubation · NA · not yet recruiting
NCT07379918 — Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer · recruiting
NCT07473869 — Smartphone Application for Automated Measurement of Capillary Refill Time (CRT) · not yet recruiting
NCT07505394 — Efficacy of a Prediction Model-based Algorithm to PREVENT Drug-induced Impulse Control Disorders in Parkinson's Disease · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04844151 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assistance Publique - Hôpitaux de Paris
Last refreshed: 6 June 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04844151.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing